clindamycin has been researched along with lactoferricin b in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hickel, R; Huth, KC; Kollmuss, M; Wuersching, SN | 1 |
1 other study(ies) available for clindamycin and lactoferricin b
| Article | Year |
|---|---|
Targeting antibiotic tolerance in anaerobic biofilms associated with oral diseases: Human antimicrobial peptides LL-37 and lactoferricin enhance the antibiotic efficacy of amoxicillin, clindamycin and metronidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Peptides; Bacteria, Anaerobic; Bacterial Infections; Biofilms; Clindamycin; Humans; Lactoferrin; Metronidazole; Microbial Sensitivity Tests; Mouth Diseases | 2021 |